Electronics giant Samsung halted clinical trials for its SAIT101, a biosimilar for Roche's blockbuster Rituxan. Though it did not offer any further explanation, a source close to the company cites...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)